Physician profile
Ronald B Killian
NPI 1205813565
$3,656.87
in general payments reported to CMS, 2019-2025
13 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $1,044 · 2021: $197 · 2022: $372 · 2023: $582 · 2024: $394 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $980.24 | 2020-2022 | |
| Paragon 28, INC. | $869.11 | 2019 | |
| Stryker Corporation | $837.97 | 2021-2025 | Mako, Axsos, Alphavent |
| Organogenesis INC. | $476.07 | 2020-2023 | Puraply |
| Orthofix Medical, INC. | $158.11 | 2021-2025 | Physio-Stim |
| Mimedx Group, INC. | $91.34 | 2024-2025 | |
| Arthrex, INC. | $90.05 | 2020 | |
| Surgenex LLC | $46.06 | 2025 | Renograft, Ardeograft, Surgraft |
| Misonix INC | $34.17 | 2019 | |
| Amgen INC. | $23.50 | 2019-2020 | |
| Depuy Synthes Sales INC. | $20.78 | 2021 | |
| Avanos Medical | $16.10 | 2024 | Trivisc Sodium Hyaluronate |
| Djo, LLC | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Killian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.